Australia markets open in 1 hour 15 minutes

Swedish Orphan Biovitrum AB (publ) (SWOBY)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
13.59-0.33 (-2.37%)
At close: 09:36AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 8.78B
Enterprise value 10.53B
Trailing P/E 47.22
Forward P/E 29.50
PEG ratio (5-yr expected) 1.46
Price/sales (ttm)4.30
Price/book (mrq)2.83
Enterprise value/revenue 4.88
Enterprise value/EBITDA 15.46

Trading information

Stock price history

Beta (5Y monthly) 0.25
52-week change 311.36%
S&P500 52-week change 328.04%
52-week high 316.50
52-week low 310.00
50-day moving average 313.17
200-day moving average 312.57

Share statistics

Avg vol (3-month) 3714
Avg vol (10-day) 364
Shares outstanding 5679.74M
Implied shares outstanding 6721.4M
Float 8216.15M
% held by insiders 1N/A
% held by institutions 1N/A
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.5
Forward annual dividend yield 43.59%
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4172.83%
Dividend date 325 Sept 2023
Ex-dividend date 421 Sept 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in SEK.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 9.26%
Operating margin (ttm)23.47%

Management effectiveness

Return on assets (ttm)4.51%
Return on equity (ttm)6.72%

Income statement

Revenue (ttm)23.14B
Revenue per share (ttm)34.69
Quarterly revenue growth (yoy)19.40%
Gross profit (ttm)N/A
EBITDA 7.77B
Net income avi to common (ttm)2.14B
Diluted EPS (ttm)0.30
Quarterly earnings growth (yoy)-25.00%

Balance sheet

Total cash (mrq)527M
Total cash per share (mrq)1.55
Total debt (mrq)19.22B
Total debt/equity (mrq)53.54%
Current ratio (mrq)0.71
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)4.74B
Levered free cash flow (ttm)2.69B